La nostra missione

Aiutare le persone a manifestare appieno il proprio
potenziale attraverso un’esperienza innovativa, adattabile e fidata.

Chi siamo

Nel sistema sanitario si contano numerose esigenze insoddisfatte e le soluzioni invasive che autorizzano i clienti a diventare partecipanti attivi della propria assistenza hanno la migliore possibilità di riuscita. Noi di Allurion apprezziamo i principi di progettazione definiti dalle preferenze dei clienti e una cultura aziendale che dà la priorità ad apertura, trasparenza e collaborazione.

I nostri valori chiave

Etica prima di tutto
Etica prima di tutto
Apertura e trasparenza
Apertura e trasparenza
Validità scientifica
Validità scientifica
Processo decisionale centrato sui dati
Processo decisionale centrato sui dati
Realizzazione dei dipendenti
Realizzazione dei dipendenti

La nostra storia

I dottori Samuel Levy e Shantanu Gaur hanno fondato Allurion Technologies nel 2009, durante il secondo anno di studio presso la Harvard Medical School, quando iniziarono a riconsiderare le percezioni diffuse relative alla perdita di peso. Per meglio comprendere i percorsi delle persone che erano sovrappeso o che stavano lottando contro l'obesità, Levy e Gaur fecero qualcosa di straordinario: ascoltarono le storie dei loro pazienti. Oggigiorno, Allurion trasforma le vite di migliaia di persone in tutto il mondo.

Levy e Gaur capirono che le persone sovrappeso erano frustrate dall'inefficacia delle diete a cui si sottoponevano, ma temevano il carattere invasivo, o semplicemente non potevano permettersi, delle procedure chirurgiche per la perdita di peso. I loro pazienti richiedevano soprattutto una procedura semplice e comoda, senza la complessità medica che accompagna altre terapie per la perdita di peso. Quando cominciarono a ricercare le soluzioni, immaginarono quello che sarebbe diventato il prodotto rappresentativo di Allurion: il Palloncino Elipse.

Il Palloncino Elipse è il risultato di 6 anni di impegno nel settore di R&S. In seguito alla marcatura CE del 2015, il Palloncino Elipse è stato utilizzato da migliaia di individui e sta rapidamente diventano il palloncino di elezione per la perdita di peso. Il palloncino è attualmente disponibile in Europa e nel Medio Oriente.

Oggigiorno, Allurion conserva la visione originale dei suoi fondatori: aiutare le persone a realizzare il loro pieno potenziale con prodotti innovativi e adattabili che arricchiscono le loro vite in modo sicuro, efficace e conveniente.

Leggi la storia completaVedi di meno
Dr. Shantanu Gaur Chief Executive Officer
Dr. Samuel Levy President
Ram Chuttani, MD Chief Medical Officer
Benoit Chardon Vice President - Sales and Marketing
Camillo Docimo Executive Director of Southern Europe Sales & International Business Development
Hubertus Schulze Zumkley Director of Sales Northern Europe
Nidal Naji Regional Director GCC Asia PAC
Javier Ibanez Executive Director of Sales LATAM
Julia Wilkins Director of Finance
Ken Malomo Director of Clinical Affairs
Chris Tomosivitch Chief Financial Officer
Bruce Horwitz Director of Intellectual Property
Kelly Houston Director of Human Resources
Bill Burke Director of Operations
Wayne Medeiros Director of Quality Assurance
John Genereux Director of Research and Development
  • image
    • Michael Davin

    As Cynosure’s Chairman, President and Chief Executive Officer from 2003 to 2017, Michael Davin oversaw sales growth from $20 million to $430 million including significant international expansion, led the company’s initial public offering and listing on the NASDAQ and executed key acquisitions. Under his leadership, Cynosure achieved compound annual revenue growth of more than 20 percent and became one of the largest and most profitable companies in the aesthetic industry. Cynosure was sold to Hologic for $1.65 billion in March 2017.

  • image
    • Todd Zavodnick

    Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry and is currently Dermavant’s Chief Executive Officer. Prior to joining Dermavant, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He previously served in global leadership roles at ZELTIQ Aesthetics prior to the company’s acquisition by Allergan, at Galderma Laboratories where he was president and general manager of North America, and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation.

  • image
    • Gail Zauder

    Gail Zauder is the Managing Partner of Elixir Advisors, a financial and strategic advisory firm she founded in 2002. She is recognized as one of the foremost advisors to creative entrepreneurs and companies in the luxury goods, beauty, and retail and apparel sectors. Prior to founding Elixir, Ms. Zauder was a Managing Director at Credit Suisse First Boston where she was global head of the Luxury Goods Investment Banking Group. During her years in Investment Banking, Ms. Zauder has been involved in more than 100 merger and acquisition and financing transactions representing over $35 billion in value.

  • image
    • Krishna Gupta

    Krishna Gupta is the Founder and Managing Partner of Romulus Capital. A venture capital firm that focuses on building, not betting on, science- and technology-enabled companies. Mr. Gupta has been involved with Allurion since 2010, and Romulus led Allurion’s $27M Series C funding. Under Mr. Gupta’s leadership, Romulus has built a powerful portfolio of innovative companies and a global investor base from more than 20 countries. Mr. Gupta has extensive experience helping high-growth companies scale to become category leaders.

  • image
    • Samuel Levy

    Samuel Levy co-founded Allurion Technologies with Shantanu Gaur in 2009. Samuel graduated summa cum laude with a B.S. in Molecular Biophysics and Biochemistry from Yale College and with an M.D. from Harvard Medical School. He was a Fulbright Scholar to France and served pharmaceutical and medical products clients as a consultant at McKinsey & Company.

  • image
    • Shantanu Gaur

    Shantanu Gaur co-founded Allurion Technologies with Samuel Levy in 2009. Shantanu completed his A.B. in Biology from Harvard College, where he graduated summa cum laude with election to Phi Beta Kappa. Shantanu received his M.D. from Harvard Medical School.

Nezam Afdhal, MD
Jordan Busch, MD, FACP
Ram Chuttani, MD
Daniel Jones, MD, MS, FACS
Elisabeth Mathus-Vliegen, MD, PhD
John Morton, MD, MPH, FACS, FASMBS
Bruce Schirmer, MD
Harold Solomon, MD
Peter D. Siersma, MD, PhD, FASGE, FACG
Richard Rothstein, MD
In memoriam: George Blackburn, MD, PhD (1936-2017)

Carriera

Ottenete successo facendo del bene.
Unitevi al nostro team in rapida crescita.

Venite a lavorare con noi.

Sedi

Headquarters - Boston
11 Huron Dr
Natick, MA 01760
United States of America

Paris
11 rue de Téhéran,
75008, Paris
France

Dubai
Prime Tower, Floor 29, Office 36,
Business Bay,
Dubai, UAE

Contattateci